Clonal expansion and not cell interconversion is the basis for the neuroblast and nonneuronal types of the SK-N-SH neuroblastoma cell line

Cancer Genetics and Cytogenetics

Volumn 143, Issue 1, 2003, Pages 80-84

  Cohen, Ninette ^a   Betts, David R ^b   Rechavi, Gideon ^a   Amariglio, Ninette ^a   Trakhtenbrot, Luba ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SUBPOPULATION; CELL TYPE; CONVERSATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; KARYOTYPING; MOLECULAR CLONING; NEUROBLAST; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SPECTROSCOPY;

EID: 0038330230     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00835-X     Document Type: Article

References (21)

1. Grovas A., Fremgen A., Rauck A., Ruymann F.B., Hutchinson C.L., Winchester D.P., Menck H.R. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. 80:1997;2321-2332.
2. Gurney J.G., Ross J.A., Wall D.A., Bleyer W.A., Severson R.K., Robison L.L. Infant cancer in the US. histology-specific incidence and trends, 1973 to 1992 J Pediatr Hematol Oncol. 19:1997;428-432.
3. Maris J.M., Matthay K.K. Molecular biology of neuroblastoma. J Clin Oncol. 17:1999;2264-2279.
4. Ross R.A., Spengler B.A., Biedler J.L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst. 71:1983;741-747.
5. Ross R.A., Biedler J.L. Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro. Cancer Res. 45:1985;1628-1632.
6. Rettig W.J., Spengler B.A., Chesa P.G., Old L.J., Biedler J.L. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res. 47:1987;1383-1389.
7. Sadee W., Yu V.C., Richards M.L., Preis P.N., Schwab M.R., Brodsky F.M., Biedler J.L. Expression of neurotransmitter receptors and myc protooncogenes in subclones of a human neuroblastoma cell line. Cancer Res. 47:1987;5207-5212.
8. Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells. expression of distinct neural crest lineages Cancer Res. 49:1989;219-225.
9. Foley J., Cohn S.L., Salwen H.R., Chagnovich D., Cowan J., Mason K.L., Parysek L.M. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res. 51:1991;6338-6345.
10. La Quaglia M.P., Manchester K.M. A comparative analysis of neuroblastic and substrate-adherent human neuroblastoma cell lines. J Pediatr Surg. 31:1996;315-318.
11. Isaacs J.S., Hardman R., Carman T.A., Barrett J.C., Weissman B.E. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines. Cell Growth Differ. 9:1998;545-555.
12. ISCN. An international system for human cytogenetic nomenclature. Mitelman F, editor. Basel: S. Karger, 1995.
13. Van Roy N., Van Limbergen H., Vandesompele J., Van Gele M., Poppe B., Salwen H., Laureys G., Manoel N., De Paepe A., Speleman F. Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines. Genes Chromosomes Cancer. 32:2001;126-135.
14. Cohn S.L., Salwen H., Quasney M.W., Ikegaki N., Cowan J.M., Herst C.V., Kennett R.H., Rosen S.T., DiGiuseppe J.A., Brodeur G.M. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. Oncogene. 5:1990;1821-1827.
15. Wada R.K., Seeger R.C., Brodeur G.M., Einhorn P.A., Rayner S.A., Tomayko M.M., Reynolds C.P. Human neuroblastoma cell lines that express N-myc without gene amplification. Cancer. 72:1993;3346-3354.
16. Lastowska M., Cotterill S., Pearson A.D., Roberts P., McGuckin A., Lewis I., Bown N. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. UK Children's Cancer Study Group and the UK Cancer Cytogenetics Group. Eur J Cancer. 33:1997;1627-1633.
17. Plantaz D., Mohapatra G., Matthay K.K., Pellarin M., Seeger R.C., Feuerstein B.G. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol. 150:1997;81-89.
18. Vandesompele J., Van Roy N., Van Gele M., Laureys G., Ambros P., Heimann P., Devalck C., Schuuring E., Brock P., Otten J., Gyselinck J., Paepe A.D., Speleman F. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer. 23:1998;141-152.
19. Vandesompele J., Speleman F., Van Roy N., Laureys G., Brinskchmidt C., Christiansen H., Lampert F., Lastowska M., Bown N., Pearson A., Nicholson J.C., Ross F., Combaret V., Delattre O., Feuerstein B.G., Plantaz D. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors. how many genetic subgroups are there? Med Pediatr Oncol. 36:2001;5-10.
20. Van Roy N., Van Limbergen H., Vandesompele J., Van Gele M., Poppe B., Laureys G., De Paepe A., Speleman F. Chromosome 2 short arm translocations revealed by M-FISH analysis of neuroblastoma cell lines. Med Pediatr Oncol. 35:2000;538-540.
21. Ambros I.M., Zellner A., Roald B., Amann G., Ladenstein R., Printz D., Gadner H., Ambros P.F. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med. 334:1996;1505-1511.